Jenna L. Voellinger
- Hematology top 10%
- Acute Myeloid Leukemia Research 4
- Multiple Myeloma Research and Treatments 3
-
- HER2/EGFR in Cancer Research 2
-
- 3D Printing in Biomedical Research 2
-
- Histone Deacetylase Inhibitors Research 2
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Edward J. KellyDanny D. ShenThomas NeumannKenneth E. ThummelBrian D. ChapronJonathan HimmelfarbZhican WangKimberly A. Muczynski
- Cited by
- HematologyOncologyPharmacology
- Partner nations
- United States
In The Last Decade
Jenna L. Voellinger
11 papers receiving 396 citations
Peers
Comparison fields: 5 of 64
- Hematology 86
- Oncology 106
- Pharmacology 33
- Biomedical Engineering 157
- Nephrology 24
Countries citing papers authored by Jenna L. Voellinger
This map shows the geographic impact of Jenna L. Voellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna L. Voellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna L. Voellinger more than expected).
Fields of papers citing papers by Jenna L. Voellinger
This network shows the impact of papers produced by Jenna L. Voellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna L. Voellinger. The network helps show where Jenna L. Voellinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jenna L. Voellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2022 | 11 | |
| 3 | 2018 | 55 | |
| 4 | 2017 | 31 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 191 | |
| 7 | 2016 | 5 | |
| 8 | 2016 | 23 | |
| 9 | 2016 | 25 | |
| 10 | 2014 | 32 | |
| 11 | 2013 | 26 |
About Jenna L. Voellinger
Jenna L. Voellinger is a scholar working on Hematology, Transplantation and Pharmaceutical Science, having authored 11 papers that have together received 408 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Histone Deacetylase Inhibitors Research (2 papers), HER2/EGFR in Cancer Research (2 papers), 3D Printing in Biomedical Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Protein Degradation and Inhibitors (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hematology (86 citations), Oncology (106 citations) and Pharmacology (33 citations). Jenna L. Voellinger has collaborated with scholars based in United States. Frequent co-authors include Edward J. Kelly, Danny D. Shen, Thomas Neumann, Kenneth E. Thummel, Brian D. Chapron, Jonathan Himmelfarb, Zhican Wang, Kimberly A. Muczynski, Yoshiyuki Yamaura and Elijah J. Weber.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.